IQVIA joins LEAPS as newest Pioneer Site The leading global provider of advanced analytics, technology solutions and contract research services to the life sciences industry will help to advance the … Read More
Paying for Cures August 2020 virtual conference recap
FoCUS hosted a virtual Paying for Cures one-day conference on August 18 examining the challenges public and private payers face when considering new cell and gene therapies. The latest in … Read More
LEAPS Monthly Recap: July 2020
Stakeholder collaboration, the gateway to patient-centered care Dr Gigi Hirsch speaks in the Frances Hamburger Institute for Community Rheumatology (FHI) Inaugural Stakeholder Virtual Roundtable Webinar FHI invited leading stakeholders within … Read More
FoCUS Monthly Recap: July 2020
RESEARCH BRIEF Pipeline analysis: 10x growth, but serious questions Updated projection of US durable cell and gene therapies product-indication approvals based on December 2019 development pipeline. Ongoing pipeline modeling by … Read More
Updated projection of US durable cell and gene therapies product-indication approvals based on December 2019 development pipeline
Ongoing pipeline modeling by the MIT NEWDIGS FoCUS team projects 10X growth from July 2020 levels, but with large uncertainties. Download FoCUS Research Brief 2020F207v51Share the research
Stakeholder collaboration, the gateway to patient-centered care
Dr Gigi Hirsch speaks in the Frances Hamburger Institute for Community Rheumatology (FHI) Inaugural Stakeholder Virtual Roundtable Webinar Summary courtesy of Frances Hamburger Institute for Community Rheumatology (FHI). Download the full Webinar … Read More
NEWDIGS offers comment on CMS Proposed Rule supporting Value-Based Purchasing
On behalf of the NEWDIGS initiative / FoCUS Project, project team members submitted comments on the recent CMS Proposed Rule supporting Value-Based Purchasing (VBP) (CMS-2482-P). With active input from an engaged … Read More
Tracking the CAR-T revolution: Analysis of clinical trials of CAR-T and TCR therapies for the treatment of cancer
Chimeric antigen receptor and T-cell receptor (CAR-T/TCR) cellular immunotherapies have shown remarkable success in the treatment of some refractory B-cell malignancies, with potential to provide durable clinical response for other … Read More
FoCUS Monthly Recap: June 2020
WHITE PAPER Tracking the CAR-T revolution: Analysis of clinical trials of CAR-T and TCR therapies for the treatment of cancerWe look at all available FDA CAR-T/TCR clinical trials for the … Read More
LEAPS Monthly Recap: June 2020
JUNE VIRTUAL DESIGN LAB RECAP Adaptive Reimbursement: Innovating for Patient Access & Better Outcomes for All Adaptive Reimbursement was explored at the NEWDIGS LEAPS Design Lab by a panel representing … Read More